Navigation Links
Investor Group Commends Jim Merselis for Joining Trinity Biotech's Board of Directors & Announces Conference Call Invitation
Date:2/12/2009

KANSAS CITY, Mo., Feb. 12 /PRNewswire/ -- An investor group in Trinity Biotech plc (Nasdaq: TRIB), an Irish based developer and manufacturer of diagnostic products, is delighted that Jim Merselis has joined the company's board of directors. In addition to expressing support for Mr. Merselis, the group has scheduled a conference call regarding important shareholder developments for 12:00 pm ET (9:00 am PT) on Tuesday, February 17, 2009.

All those interested in participating in the call should dial 888 300 5688 and reference Conference ID 85881585.

Commenting on the news, Mr. Reidy stated, "We are pleased Jim has agreed to serve, bringing the total of independent directors to two. While Jim's agreement to join as part of our broader effort is honorable, we continue our call to action for true board oversight and management accountability. We look forward to Jim remaining as part of our new board immediately following the pending action to remove and replace the current board."

Commenting on the campaign and pending conference call, Mr. Reidy stated, "Much progress has been made that we look forward to sharing with our fellow shareholders, and we remain committed to our goals to effect the changes needed to unlock shareholder value and provide the level of transparency we have continued to advocate."

Tom Reidy, 816-260-8476, tjreidy3@hotmail.com


'/>"/>
SOURCE KC Investor Group
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Champions Biotechnology, Inc.s Doug Burkett, PhD, to Present at BIO CEO & Investor Conference
2. Genaera to Present at BIO CEO & Investor Conference
3. Rigel to Present at BIO CEO & Investor Conference
4. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the BIO CEO and Investor Conference in New York City
5. Arena Pharmaceuticals to Present at the BIO CEO & Investor Conference
6. VirtualScopics to Present at 11th Annual BIO CEO & Investor Conference
7. ISTA Pharmaceuticals to Present at the 11th Annual BIO CEO & Investor Conference
8. Nile Therapeutics to Present at the 2009 BIO CEO & Investor Conference
9. SuperGen to Present at BIO CEO & Investor Conference on February 10, 2009
10. Haemacure to Present at the 11th Annual BIO CEO & Investor Conference
11. Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released a ... books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture of ... have tossed it off as mere rubbish, but Yisrayl Hawkins says that is because ...
(Date:10/13/2017)... ... 2017 , ... “America On The Brink”: the Christian history of the United ... the creation of published author, William Nowers. Captain Nowers and his wife, Millie, ... spent thirty years in the Navy. Following his career as a naval aviator ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
(Date:10/12/2017)... FL (PRWEB) , ... October 12, 2017 , ... On ... holding a treadmill relay – Miles by Moonlight to raise money for the American ... $300 or more. , Teams will work together to keep their treadmills moving ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, Inc. ... earnings conference call and webcast on Friday, November 3, ... (EDT) and ending at approximately 8:30 a.m. (CDT) / ... the company,s 2017 financial performance and guidance for 2018, ... initiatives to enhance operational performance, and long-range financial outlook ...
(Date:9/25/2017)...  EpiVax, Inc., a leader in the fields ... announced the launch of EpiVax Oncology Inc., a ... cancer vaccines. EpiVax has provided $500,000 in seed ... technologies to the new precision immunotherapy venture. Gad ... as Chief Executive Officer. Gad brings over 25 ...
(Date:9/19/2017)... , Sept. 19, 2017   ZirMed Inc ., ... analytics, today announced that it has been ranked #1 by ... Black Book™ Rankings 2017 User Survey. ZirMed was recognized ... for large hospitals and medical centers over 200 beds and ... Book,s healthcare technology user survey history. ...
Breaking Medicine Technology: